PAOLETTA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 748
EU - Europa 102
AS - Asia 68
Totale 918
Nazione #
US - Stati Uniti d'America 748
CN - Cina 37
IT - Italia 32
VN - Vietnam 18
FI - Finlandia 17
DE - Germania 13
GB - Regno Unito 12
SG - Singapore 11
UA - Ucraina 10
SE - Svezia 8
IE - Irlanda 4
AT - Austria 3
IN - India 2
CZ - Repubblica Ceca 1
FR - Francia 1
RO - Romania 1
Totale 918
Città #
Fairfield 142
Houston 84
Ashburn 64
Woodbridge 56
Seattle 54
Chandler 48
Cambridge 45
Jacksonville 45
Wilmington 42
Ann Arbor 21
Dong Ket 18
Princeton 18
San Diego 14
Beijing 13
Des Moines 10
Roxbury 10
Medford 8
Boardman 7
Nanjing 7
Cagliari 6
Helsinki 6
Columbus 4
Dublin 4
Florence 4
Novara 4
Rome 3
Changsha 2
Jiaxing 2
Lanzhou 2
London 2
Munich 2
Norwalk 2
Ogden 2
Shenyang 2
Singapore 2
Tianjin 2
Trieste 2
Vienna 2
Camerino 1
Greve in Chianti 1
Hebei 1
Kharkiv 1
Linyi 1
Messina 1
Nanchang 1
Padova 1
Prescot 1
Santa Maria Capua Vetere 1
Soncino 1
Washington 1
Totale 773
Nome #
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA(3) Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 105
A Novel Generalized 3D-QSAR Model of Camptothecin Analogs 98
Pyrazolo[4,3-: E] [1,2,4]triazolo[1,5-c] pyrimidines to develop functionalized ligands to target adenosine receptors: Fluorescent ligands as an example 83
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process 82
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition 82
Revisiting a Receptor-Based Pharmacophore Hypothesis for Human A2AAdenosine Receptor Antagonists 77
Fluorescent ligands for adenosine receptors 69
Exploring the Directionality of 5-Substitutions in a New Series of 5-Alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a Strategy To Design Novel Human A3Adenosine Receptor Antagonists. 62
Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. 61
Designing adenosine receptors antagonists using an in silico approach 61
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. 54
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: a preliminary receptor-driven SAR profile 51
The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A(3) Adenosine Receptor Antagonists 35
Totale 920
Categoria #
all - tutte 3.875
article - articoli 3.519
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 28 6 11 12 25 19 22 26 23 22 18 9
2020/2021123 7 9 3 11 2 13 1 11 20 7 16 23
2021/2022175 7 20 32 6 3 2 9 25 3 7 27 34
2022/2023121 24 2 0 6 28 28 0 9 13 1 8 2
2023/2024116 3 15 17 12 12 12 2 18 4 3 12 6
Totale 920